An Injectable Epigenetic Autophagic Modulatory Hydrogel for Boosting Umbilical Cord Blood NK Cell Therapy Prevents Postsurgical Relapse of Triple‐Negative Breast Cancer-Reference-Cited by-同舟云学术

An Injectable Epigenetic Autophagic Modulatory Hydrogel for Boosting Umbilical Cord Blood NK Cell Therapy Prevents Postsurgical Relapse of Triple‐Negative Breast Cancer

Published:2022-06-16 Issue:23 Volume:9 Page:2201271
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Advanced Science

Author:

Gong Yihang¹,Chen Wenjie²,Chen Xiuxing³,He Yizhan²,Jiang Hua⁴,Zhang Xijian¹,Pan Lijie²,Ni Beibei²,Yang Fan²,Xu Yan²,Zhang Qi²,Zhou Lei⁵,Cheng Yusheng¹^ORCID

Affiliation:

1. Department of Hepatic Surgery and Liver Transplantation Center & Guangdong Provincial Key Laboratory of Liver Disease Research The Third Affiliated Hospital Sun Yat‐sen University Guangzhou 510630 China

2. Biotherapy Centre & Cell‐Gene Therapy Translational Medicine Research Centre The Third Affiliated Hospital Sun Yat‐sen University Guangzhou 510630 China

3. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou 510120 China

4. Department of Breast & Thyroid Surgery The Third Affiliated Hospital Sun Yat‐sen University Guangzhou 510630 China

5. Guangzhou Key Laboratory of Spine Disease Prevention and Treatment Department of Spine Surgery The Third Affiliated Hospital Guangzhou Medical University Guangzhou 510150 China

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202201271

Reference58 articles.

1. Cancer statistics, 2022

2. Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease

3. HTR1A Inhibits the Progression of Triple‐Negative Breast Cancer via TGF‐βCanonical and Noncanonical Pathways

4. Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells

5. ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing Ovarian Cancer Therapeutics: The Role of Targeted Drug Delivery Systems;International Journal of Nanomedicine;2024-09

2. Versatile hydrogel-based drug delivery platform for multimodal cancer therapy from bench to bedside;Applied Materials Today;2024-08

3. Detailed role of Let-7e in human diseases;Pathology - Research and Practice;2024-08

4. Advances in Polymeric Nanomaterial‐mediated Autophagy for Cancer Therapy;ChemBioChem;2024-07-26

5. Integrated Analysis of Single-Cell and Bulk RNA-Seq Data reveals that Ferroptosis-Related Genes Mediated the Tumor Microenvironment predicts Prognosis, and guides Drug Selection in Triple-Negative Breast Cancer;2024-07-06